Introduction

The influence of intraocular lens (IOL) tilt on postoperative refraction was clinically described during the development of the first IOL power calculation formulas1,2,3. Later, this issue and the consequences of IOL misalignment were elegantly explained using paraxial optics4,5,6. As newer formulas and toric IOLs were developed and residual refraction improved, this topic gained even more importance7,8. The sensitivity of multifocal and extended depth of focus (EDOF) IOLs to misalignment prompted researchers to investigate the topic using optical bench setups8,9 and ocular wavefront measurements10,11. More recently, ray-tracing software has been used to simulate synthetic ocular models to evaluate IOL tilt and decentration12,13.

Scheimpflug imaging and anterior segment optical coherence tomography (AS-OCT) have enabled clinical evaluation of IOL tilt and decentration. Studies report mean tilt values between 2° and 5°, depending on factors such as axial length, IOL haptics, capsular tension ring use, and preoperative crystalline lens tilt14,15. These factors also influence the sagittal and meridional displacement of the IOL, with typical decentration values around 0.2–0.3 mm16. Both tilt and decentration can impair visual quality by inducing high-order aberrations (HOAs), and in more extreme cases, may reduce visual acuity (VA). Some studies suggest that decentration has a more significant impact on vision than tilt, although both are influenced by IOL design17,18. The visual impact of decentering a spherical IOL is less pronounced than with aspheric designs; however, tilt appears to affect both types similarly19,20. IOL tilt is more strongly correlated with coma-like aberrations, while both tilt and decentration contribute to induced astigmatism21,22.

As premium IOLs evolve rapidly, more sophisticated designs demand a deeper understanding of ocular optics. While optical bench simulations have provided valuable insights into IOL misalignment, and clinical studies have documented its effects on visual acuity, few studies have combined both perspectives to assess the impact on ocular aberrations comprehensively. The aim of this study is to determine whether the optical degradation induced by IOL tilt and decentration, quantified using individualized synthetic eye models built from real postoperative data, translates into measurable clinical changes in subjective refraction and BCVA. In addition, we evaluated the internal consistency of the model by comparing the objective prescriptions derived from ray-tracing analysis with the subjective refraction obtained in each patient.

Methods

Settings

This cross-sectional study was conducted at Fundación Jiménez Díaz University Hospital between November 2023 and June 2024. The local institutional review board (Comité de Etica de la Investigación Fundación Jiménez Diaz. Code: PIC204-24) approved the study protocol, which complies with the tenets of the Declaration of Helsinki. Written informed consent was obtained from all subjects prior to the commencement of the study, following an explanation of the nature and possible consequences of the study.

Patient eligibility

Patients who underwent uneventful cataract surgery of both eyes and implanted with Clareon® CNAT0 with a minimum follow-up of 3 months were included. The exclusion criteria comprehend amblyopia, retinal or corneal or any other ocular disease that could affect the patient’s vision performance. Also, any patient with history of ocular surgery such as refractive surgery or interventions that could affect the capsule-bag integrity like Nd-YAG capsulotomy was excluded.

Measurement protocol

Subjective refraction to obtain the best corrected visual acuity (BCVA) was performed by the same experienced optometrist (ASL) using ETDRS chart. One drop of tropicamide (1%) was instilled for the next measurements.

Postoperative biometry using IOL-Master 700 (Carl Zeiss Meditec, AG, Jenna, Germany, version 1.90.33.04) was used to acquire axial length. Patients anterior segment was measured with AS-OCT CASIA II (TOMEY corp, Nagoya, Japan, version 50.6B.07) using the cataract protocol examination. Only measurements labeled as OK by the instrument were included in this study. IOL edge detection was performed by a researcher (GVR) using the semi-trace method included in the AS-OCT software.

IOL parametrization

The anterior radii of curvature and central thickness of each implanted IOL were measured using the AS-OCT software. Although the software also reports the posterior radius of curvature, accurate identification of the posterior IOL surface was often impaired by the proximity of the posterior capsule, leading to acquisition errors.

To address this limitation, it was assumed that the labeled paraxial power of IOL matched its nominal value. Based on this assumption and using the refractive index provided by the manufacturer (Nd = 1.55, at 35 °C), the posterior radius of curvature was calculated such that the combination of anterior radius, central thickness, and material index would result in the labeled paraxial power.

Each IOL’s anterior surface was then modeled as a fourth order even asphere, excluding the 2nd-order term. The conic constant (k) and fourth-order aspheric coefficient (α₄) were optimized in Zemax OpticStudio to ensure that the IOL corrected − 0.20 μm of fourth-order corneal spherical aberration (Zernike term) in a physiological model eye, assuming a 6.0 mm entrance pupil.

Synthetic eye model and simulating different scenarios

Ansys Zemax OpticStudio (v 22.1) was used to build the eye model. Coordinates breaks were used to include pupil decentration, IOL tilt and decentration and corneal angle shift of the principal axes (Z-axis tilt). The anterior and posterior corneal surface were included as a biconic surface with data from IOL Master 700 principal meridians (setting conic constant to zero). The iris was represented by a stop surface of pupil’s patient diameter and situated 0.75 millimeters before the IOL anterior surface. IOL anterior surface was described as a fourth order even asphere and a posterior standard surface, adhering to the data collected by the AS-OCT and the IOL power labelled by manufacturer. The system setting was adjusted for a wavelength of 550 nm with no field modification. The selected pupil for the analysis was 4 mm. The refractive indices used in this model were 1.3752 for the cornea and 1.336 for the aqueous and vitreous humors. More information is available in Fig. 1.

Fig. 1
figure 1

Example for the first analyzed eye included in this study, revealing the general settings to build the synthetic eye model.

Four scenarios were simulated using this eye model. The first situation was with the IOL totally aligned. In the second one, the measured IOL decentration (AS-OCT) was introduced, then the IOL tilt was set and finally the IOL decentration was set to zero. Therefore, four scenarios were evaluated as “Aligned”, “Decentration”, “Decentration + tilt” and “Tilted” respectively. The wavefront phase and its associated Zernike coefficients values (up to sixth order) were collected for each situation.

Objective synthetic refraction

A total of three refractions for each of the described scenarios were obtained for each patient derived from the synthetic ocular wavefront. Two objective refractions were directly obtained from the Zernike coefficient values: minimum root min square (MinRMS) and paraxial curvature matching (PCM)23. Another refraction was calculated by maximizing the retinal image quality weighted by a neural function24. The selected metric was the visual strehl in the special domain (VSX). This was performed using an iterative process of testing lenses with the aberration map and maximizing the metric value. The following equation describes how we calculate this metric:

$$\:VSX=\:\frac{\iint\:PSF\:\left(x,y\right)*iCSF\:\left(x,y\right)\:dxdy}{\iint\:{PSF}_{DL}\:\left(x,y\right)*iCSF\:\left(x,y\right)dxdy}$$

Where PSF is the point spread function and the iCSF is the inverse fourier transform of the contrast sensitivity function (CSF)25.

The optimizing process was carried out testing a combination of sphero-cylindrical lenses with a range from − 3 to 3 D in steps of 0.25 D. The step for the refractive axis was 5º, from 0 to 175 degrees. These values were converted into power vectors (M, J0 and J45) and finally into their equivalent Zernike coefficients Z (2,0), Z (2,-2) and Z (2,2). These variables were converted into wavefront error in microns and added to the original ocular wavefront calculating the new value of the VSX. We selected the sphero-cylindrical prescription that maximize the VSX value.

Internal consistency analysis of the synthetic model

To assess the consistency of the eye model, the predicted visual (VApred) acuity was estimated by identifying the intersection between the radial modulation transfer function (MTFr) and the contrast sensitivity threshold26. Additionally, the objective prescriptions were derived from the scenario IOL decentration and tilt, which replicates the actual clinical setting in the synthetic eye model. This comparison was evaluated twofold, with the subtraction (subjective prescription – objective prescription) and by the Bland-Altman agreement analysis method.

Impact of IOL Tilt and decentration in visual performance

We evaluated this question using two complementary approaches: variables derived from the synthetic eye model, which describe the optical impact of misalignment, and clinical measurements obtained from the same eyes.

The synthetic eye model allows the statistical comparison of the image quality metrics such as VSX or the optical aberrations (RMS astigmatism and RMS Coma) for the different simulated scenarios (Aligned’, ’Decentration’, Tilt’ and Decentration and tilt’). These variable changes were assessed using ANOVA statistical tests, with p-values adjusted for multiple comparisons using the Bonferroni correction. A p-value < 0.05 was considered statistically significant after correction. The image quality metrics obtained for each scenario were compared using the Wilcoxon signed-ranked test and box and whiskers plots analysis.

Concerning the clinical measurements, we studied the IOL positioning (tilt and decentration) and BCVA. First, we performed a partial correlation analysis to determine the relationship between IOL tilt, decentration and BCVA. But also, we explore the BCVA differences between patients with high IOL tilt (more than third quartile) or decentration to those that presented low values (less than first quartile) of these variables. For that purpose, we used Mann-Whitney U test with the mentioned statistical threshold.

Results

The demographic and clinical characteristics of the sample are summarized as follows. A total of 105 right eyes from 105 participants (53% females and 47% males) were included in this study. The mean patients age was 73.35 ± 8.39 years old and follow-up period was 9.41 ± 4.54 months after cataract surgery. A statistical summary of the main clinical variables is presented in Table 1. The main modulus of the vectors tilt and decentration were 5.19 ± 1.28° and 0.25 ± 0.13 mm, respectively. The study of the IOL tilt revealed a tendency, the nasal-superior IOL edge was shifted towards the cornea compared to the temporal edge. The maximum value for tilt was 9.3º (eye 12) and decentration was 0.83 mm (eye 36).

Table 1 Summarize the results for the demographic and clinical variables.

Synthetic model outcomes and internal consistency

We first evaluated the agreement between simulated and clinical parameters, as this reflects the internal consistency of the synthetic model. The mean difference and 95% confidence interval (95%CI) between VApred and BCVA were − 0.07 95% CI(-0.09,-0.05) LogMAR. The Bland-Altman analysis showed a low and upper limit of agreement of -0.27, 0.14 LogMAR respectively (Fig. 2).

Fig. 2
figure 2

Bland-Altman plot that shows the agreement between the predicted visual acuity using the intersection value of the threshold function and the average modulation transfer function.

We then compared the objective prescriptions derived from the synthetic wavefront with the clinical subjective refraction. The objective prescriptions calculation varies with every single scenario and their mean differences with the subjective prescription are represented in Table 2. The scenario where decentration and tilt were represented showed the minimum differences with the subjective prescription. Further details for the comparison between this scenario prescriptions and the clinical subjective prescription are extended in Fig. 3.

Table 2 Showed the mean and 95% confidence interval for each objective prescription calculated for each scenario and the subjective prescription.
Fig. 3
figure 3

Objective and subjective prescriptions comparative. Above the agreement using a Bland-Altman plot. Below is the histogram that represents the number of eyes (Y-axis) and the difference in diopters (X-axis) for the power vectors (M, J0 and J45).

Simulated optical impact of IOL misalignment

We next quantified how tilt and decentration affected the optical quality within the synthetic model. The wavefront error changed significantly for the RMS coma (p < 0,001), where the aligned scenario showed zero coma values and it increased its value through the next scenarios. Spherical and astigmatism aberrations slightly changed with IOL tilt and decentration.

We also evaluated how the simulated objective prescriptions changed across the four scenarios. While the objectives prescriptions MinRMS and PCM did not show differences when tilt and decentration were included, the M variable showed a progressive decline. In contrast this variable changed significantly for the optimized VSX prescription. Once again, the lowest value for M was found for the scenario were both, tilt and decentration were included. More details could be found in Table 3.

Table 3 Mean and standard deviation of the objective prescriptions in power vector notation and the VSX metrics value associated through different simulated scenarios. ANOVA (corrected p-value) corresponds to Bonferroni-adjusted p-values calculated across all scenario comparisons.

We further assessed how tilt and decentration influenced global image-quality metrics derived from the synthetic model. The VSX metric statistically changed between scenarios, reducing its value as long as tilt and decentration were involved. This happened for the three objective prescriptions assessed in this study and we found that IOL tilt impacts more than decentration (p < 0.001). These differences are represented numerically in Fig. 4. Additionally, the convolution images illustrate the deterioration produced in the most extreme cases of the sample (Fig. 5).

Fig. 4
figure 4

Visual Strehl ratio (VSX) comparison across four intraocular lens (IOL) positioning scenarios: perfectly aligned, decentered, tilted, and combined decentration and tilt. All pairwise comparisons showed statistically significant differences (***p < 0.001) using Wilcoxon rank sum test.

Fig. 5
figure 5

Representation of convolution image in three different cases. The first row shows an eye with IOL tilt and decentration within normal limits. The second row corresponds to the case with maximum IOL tilt, and the third row represents a case with significant IOL decentration.

Clinical impact of IOL Tilt and decentration

We analyzed whether the clinical misalignment of the IOL was associated with measurable changes in BCVA. The partial Spearman correlation between IOL tilt and BCVA, controlling IOL decentration, was not statistically significant (r = 0.07, 95% CI [-0.12, 0.26], p = 0.48). Similarly, when assessing the partial correlation between IOL decentration and BCVA while controlling for IOL tilt, no significant association was found (r = 0.13, 95% CI [-0.06, 0.32], p = 0.18). When comparing the BCVA between groups with low and high IOL tilt, no significant differences were observed (p-value = 0.23). Same result was obtained when comparing BCVA between groups with high and low IOL decentration (p-value = 0.29).

Discussion

This study was designed to assess whether the optical degradation resulting from IOL tilt and decentration, quantified through individualized synthetic ocular models, produces clinically measurable changes in subjective refraction or visual acuity. A secondary objective was to evaluate the internal consistency of the synthetic model by analyzing the agreement between the simulated objective prescriptions and the subjective refraction obtained in each case.

Another notable contribution of this study is the characterization of monofocal aspheric IOLs. Using their anterior radius, labeled power, and manufacturer-reported spherical aberration, we were able to implement these lenses into ray-tracing simulations. Despite the aforementioned challenges, we successfully modeled the optical aberrations of the eye and evaluated the impact of IOL tilt and decentration on visual quality. A major strength of this study is the integration of clinical data with theoretical analysis, helping to bridge the gap between basic research and clinical practice.

The study findings are in accordance with the theoretical changes produced by IOL tilt proposed by Atchison et al.5, as the M value for every prescription varies when IOL tilt and decentration are present because of the variation of the effective power of the IOL. We did not appreciate great changes in terms of the astigmatism components, probably because the IOL model selected for this study was aspherical.

Our findings show that both IOL tilt and decentration induce statistically significant coma aberrations. For IOL decentration, we found a mean value of 0.25 ± 0.13 mm which induced coma aberration of 0.11 ± 0.06 μm. This result is in accordance with Perez-Gracia19 which reported a coma RMS value around 0.05–0.1 μm for 0.25 mm IOL decentration. In the same line, Perez-Merino et al.12 reported an RMS coma from 0.10 μm to 0.22 μm for 0.4 mm decentration. Our result in coma aberration is within the range of normal reported values from other authors. These results are strongly influenced by the pupil diameter and the IOL model selected (aspherical or spherical). The mean coma aberration induced by IOL tilt (5.19 ± 1.28°) in this study was 0.21 ± 0.07 μm. Other studies reported similar mean values for IOL tilt, from 2 to 6 degrees inducing a coma-like aberration from 0.1922 to 0.4 microns17,19. The variability depends on several factors, such as the IOL power and design or the pupil used for the analysis.

VSX metrics proved highly sensitive to IOL tilt and decentration, showing a marked reduction in value as these misalignments increased. This behavior may be attributed to the prismatic effect caused by coma aberration on the point spread function. Interestingly, the low VSX values observed in the “tilt and decentration” scenario contrast with the good clinical BCVA outcomes.

Despite this, the correlation between the degree of tilt and decentration and the resulting BCVA was weak when an aspherical IOL was implanted, suggesting limited clinical impact. This raises the question of whether such induced aberrations could have a more pronounced effect in the context of multifocal IOLs, which are known to be more susceptible to higher-order aberrations and demand higher optical quality for optimal function.

This study has several limitations, the most critical is the representation of the cornea. The IOLMaster 700 does not provide patient-specific corneal asphericity, and the corneal surfaces in the model were therefore implemented as biconics with conic constants set to zero. This approximation cannot reproduce the exact aspheric geometry of each cornea and may introduce small shifts in the absolute values of the simulated aberrations. However, the purpose of the model was to evaluate relative changes across the different misalignment scenarios, and these changes are dominated by IOL tilt and decentration. For this reason, the impact of the missing asphericity is expected to be modest and does not alter the main trends observed. Another limitation is the unavailability of exact IOL parameters from manufacturers, as such information remains proprietary. Also, our model assumes a monochromatic light source centered at 550 nm, whereas real vision involves a broad spectrum of wavelengths and complex neural processing, which are not fully accounted for in this study. Another limitation is that no a priori sample size calculation was performed. With 105 eyes, the study has adequate power to detect moderate associations but limited ability to detect small effects. Therefore, while the absence of strong correlations is supported by the data, very small associations cannot be excluded. Another limitation is that the posterior IOL radius was estimated rather than directly measured, as AS-OCT does not reliably capture the posterior surface. This estimation uses the labelled IOL power, which under ISO 11979-2 represents the paraxial power within narrow tolerance limits. Once the anterior radius and central thickness are fixed by OCT, variations within these limits produce only minor adjustments in the inferred posterior curvature and small changes in the downstream ray-tracing results. For this reason, this approximation is not expected to materially affect the conclusions.

Future research should focus on improving the precision of corneal surface modeling, possibly by integrating data from advanced imaging modalities such as Scheimpflug tomography. Additionally, efforts to access and incorporate manufacturer-specific IOL design parameters would enhance the accuracy of simulations. Expanding the model to include polychromatic light and retinal image processing would provide a more comprehensive understanding of the visual impact of IOL misalignment.

Although IOL tilt and decentration induced statistically significant coma aberration in the optical eye model, the analysis of clinical variables did not reveal a consistent relationship with visual outcomes. This suggests that the magnitude of coma induced by the observed levels of misalignment may not be sufficient to significantly impair the best-corrected visual acuity in eyes implanted with the studied aspheric IOL. However, further studies are needed to determine whether the aberrations induced by IOL tilt and decentration have a more relevant impact on visual performance when multifocal IOLs are implanted.